Phosphorylation: new star of pathogenesis and treatment in steatotic liver disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Phosphorylation: new star of pathogenesis and treatment in steatotic liver disease ; volume:23 ; number:1 ; day:17 ; month:2 ; year:2024 ; pages:1-18 ; date:12.2024
Lipids in health and disease ; 23, Heft 1 (17.2.2024), 1-18, 12.2024
- Creator
-
Lv, Tiansu
Lou, Yan
Yan, Qianhua
Nie, Lijuan
Cheng, Zhe
Zhou, Xiqiao
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12944-024-02037-9
- URN
-
urn:nbn:de:101:1-2404250829295.831975599291
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:49 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lv, Tiansu
- Lou, Yan
- Yan, Qianhua
- Nie, Lijuan
- Cheng, Zhe
- Zhou, Xiqiao
- SpringerLink (Online service)
Other Objects (12)
Role of Glucocorticoids in Metabolic Dysfunction-Associated Steatotic Liver Disease
Integrating social nutrition principles into the treatment of steatotic liver disease
More than additive effects on liver triglyceride accumulation by combinations of steatotic and non-steatotic pesticides in HepaRG cells
Fat causes necrosis and inflammation in parenchymal cells in human steatotic liver
Interplay between YAP/TAZ and metabolic dysfunction-associated steatotic liver disease progression
Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk: a comprehensive review
Opportunistic assessment of steatotic liver disease in lung cancer screening eligible individuals
Astrocytes: Emerging stars in leukodystrophy pathogenesis
Effects of semaglutide-loaded lipid nanocapsules on metabolic dysfunction-associated steatotic liver disease
Single‐cell transcriptomics stratifies organoid models of metabolic dysfunction‐associated steatotic liver disease
Steatotic liver disease associated with 2,4-dienoyl-CoA reductase 1 deficiency
Rapid deterioration of steatotic liver disease due to portal vein stenosis after pancreaticoduodenectomy
Role of Glucocorticoids in Metabolic Dysfunction-Associated Steatotic Liver Disease
Integrating social nutrition principles into the treatment of steatotic liver disease
More than additive effects on liver triglyceride accumulation by combinations of steatotic and non-steatotic pesticides in HepaRG cells
Fat causes necrosis and inflammation in parenchymal cells in human steatotic liver
Interplay between YAP/TAZ and metabolic dysfunction-associated steatotic liver disease progression
Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk: a comprehensive review
Opportunistic assessment of steatotic liver disease in lung cancer screening eligible individuals
Astrocytes: Emerging stars in leukodystrophy pathogenesis
Effects of semaglutide-loaded lipid nanocapsules on metabolic dysfunction-associated steatotic liver disease
Single‐cell transcriptomics stratifies organoid models of metabolic dysfunction‐associated steatotic liver disease
Steatotic liver disease associated with 2,4-dienoyl-CoA reductase 1 deficiency
Rapid deterioration of steatotic liver disease due to portal vein stenosis after pancreaticoduodenectomy
Role of Glucocorticoids in Metabolic Dysfunction-Associated Steatotic Liver Disease
Integrating social nutrition principles into the treatment of steatotic liver disease
More than additive effects on liver triglyceride accumulation by combinations of steatotic and non-steatotic pesticides in HepaRG cells
Fat causes necrosis and inflammation in parenchymal cells in human steatotic liver
Interplay between YAP/TAZ and metabolic dysfunction-associated steatotic liver disease progression
Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk: a comprehensive review
Opportunistic assessment of steatotic liver disease in lung cancer screening eligible individuals
Astrocytes: Emerging stars in leukodystrophy pathogenesis
Effects of semaglutide-loaded lipid nanocapsules on metabolic dysfunction-associated steatotic liver disease
Single‐cell transcriptomics stratifies organoid models of metabolic dysfunction‐associated steatotic liver disease
Steatotic liver disease associated with 2,4-dienoyl-CoA reductase 1 deficiency